Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 9:29 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1249–1272 of 3,978 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Inflammation, Oxidative Stress, Immune Dysfunction
Interventions: Pistachios; Other
Lead sponsor: Appalachian State University; Other
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Kannapolis, North Carolina

Conditions: Mild Cognitive Impairment (MCI), Older Adults With Cognitive Decline, Older Adults
Interventions: Not listed
Lead sponsor: BioSensics; Industry
Eligibility: 55 Years and older
Enrollment: 100 participants
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Stroke With Hemiparesis
Interventions: Transfer of grasp control across hands; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 21 Years to 90 Years
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: New York, New York

Conditions: Spinal Cord Injuries, Neurogenic Lower Urinary Tract Dysfunction, Neurogenic Bladder
Interventions: Not listed
Lead sponsor: Medstar Health Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Alcohol Use, Unspecified, Sexual Dysfunction, Sexual Assault
Interventions: AWARE; Behavioral
Lead sponsor: Lifespan; Other
Eligibility: 18 Years to 24 Years · Female only
Enrollment: 86 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Evaporative Dry Eye
Interventions: iLux 2020 System; Device
Lead sponsor: Tear Film Innovations, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 3
States / cities: Encinitas, California • San Diego, California

Conditions: ME/CFS, Long COVID, PASC
Interventions: Pyridostigmine, Low-Dose Naltrexone, Placebo; Drug · Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 70 Years
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Alzheimer Disease, Mild Cognitive Impairment, Dementia
Interventions: SPARK Cognitive Status Indicator (software support data collected via EEG); Diagnostic Test
Lead sponsor: Spark Neuro Inc.; Industry
Eligibility: 65 Years to 90 Years
Enrollment: 600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Survivors of Childhood Cancer, Bladder Dysfunction
Interventions: Non-invasive Urodynamic Test (niUDS), Urinary proteomic screen, Dysfunctional Voiding Symptom Score Survey (DVSS); Diagnostic Test · Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 5 Years to 13 Years
Enrollment: 152 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2031
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Alzheimer Disease
Interventions: ACU193, Placebo; Drug
Lead sponsor: Acumen Pharmaceuticals; Industry
Eligibility: 55 Years to 90 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 17
States / cities: Scottsdale, Arizona • Anaheim, California • Newport Beach, California + 14 more

Conditions: Hypertension
Interventions: Clonidine, Nitroglycerin transdermal, Dipyridamole/ Aspirin (Aggrenox), Desmopressin (DDAVP), Sildenafil, Nifedipine, Hydralazine, Hydrochlorothiazide, Placebo, Bosentan, Diltiazem, Eplerenone, guanfacine, L-arginine, captopril, carbidopa, losartan, metoprolol tartrate, nebivolol hydrochloride, prazosin hydrochloride, tamsulosin hydrochloride, Head-up tilt., aliskiren, Local heat stress; Drug · Dietary Supplement · Other
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 152 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2017
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Procedures Requiring Anesthesia
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: 6 Years to 11 Years
Enrollment: 162 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2018
U.S. locations: 3
States / cities: Davis, California • Oakland, California • San Francisco, California

Conditions: Delirium, Critical Illness, Sedation Complication, Executive Dysfunction, Post Traumatic Stress Disorder
Interventions: Dexmedetomidine, Midazolam; Drug
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 44 Weeks to 11 Years
Enrollment: 372 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Diabetes, Cancer, Multiple Sclerosis, Arthritis, Parkinson's Disease, Cognitive Disorders, Brain Injury, Stroke
Interventions: Exergame, Home based balance training; Procedure
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Hypertension
Interventions: Chlorthalidone 12.5 mg, Hydrochlorothiazide 25 mg, Placebo; Drug
Lead sponsor: Creighton University; Other
Eligibility: 19 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Heart Failure, Mild Cognitive Impairment
Interventions: Yoga intervention, Control condition; Behavioral
Lead sponsor: Auburn University; Other
Eligibility: 55 Years to 70 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Auburn, Alabama

Conditions: Inflammation, Platelet Dysfunction
Interventions: Nitric Oxide, Placebo, INOmax; Drug · Device
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: Up to 1 Year
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Health Services Accessibility, Rural Health, Medically Underserved Area, Preventive Health Services, Patient Participation, Health Behavior, Aging, Cardiovascular Diseases, Metabolic Syndrome, Cognitive Dysfunction, Frailty, Activities of Daily Living, Health Related Quality of Life, Health Equity, Telemedicine
Interventions: AI-Assisted Screening Interpretation (AI Reads), Human-Only Screening Interpretation; Behavioral
Lead sponsor: William Brandenburg, MD; Industry
Eligibility: 18 Years and older
Enrollment: 1,000,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2099
U.S. locations: 1
States / cities: Boulder, Colorado

Conditions: Corneal Edema, Corneal Endothelial Dysfunction, Corneal Endothelial Dystrophy, Fuchs Dystrophy, Fuchs Endothelial Corneal Dystrophy, Pseudophakic Bullous Keratopathy, Bullous Keratopathy, Endothelial Dysfunction, Moderate Corneal Endothelial Decompensation
Interventions: EO2002, EO2002 low dose, EO2002 mid dose, EO2002 high dose; Biological
Lead sponsor: Emmecell; Industry
Eligibility: 21 Years and older
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 8
States / cities: Greater Los Angeles, California • San Diego, California • Miami, Florida + 5 more

Conditions: Cognitive Dysfunction
Interventions: Fluoxetine, Placebo; Drug · Other
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 21 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 2
States / cities: Duarte, California • Los Angeles, California

Conditions: Alzheimer Disease, Cognitive Impairment
Interventions: SPARK Test; Device
Lead sponsor: Spark Neuro Inc.; Industry
Eligibility: 55 Years to 85 Years
Enrollment: 185 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 7
States / cities: Loma Linda, California • Englewood, Colorado • Ocala, Florida + 4 more

Conditions: Diastolic Dysfunction
Interventions: Dobutamine stress echo (DSE), Atropine bolus; Drug
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 18 Years to 65 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Mild Cognitive Impairment
Interventions: avocado, potato or chickpea; Other
Lead sponsor: Tufts University; Other
Eligibility: 50 Years and older
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Chronic Pain
Interventions: Behavior Change Coaching, Nutrition, Autonomic Recalibration, Dry Needling, Osteopathic Manipulative Treatment, Counseling Psychology, Multiple Treatments; Behavioral · Other · Procedure
Lead sponsor: Edward Via Virginia College of Osteopathic Medicine; Other
Eligibility: 21 Years to 80 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Auburn, Alabama

Search by objective public record fields.

Pistachios, Performance, Metabolomics

Wearable Sensor for Early Detection and Monitoring of Cognitive Decline

Transfer of Grasp Control Across Hands After Stroke

Patient and Caregiver Perspectives on Intravesical Instillations for Urinary Symptoms

Reducing Alcohol Use and Sexual Dysfunction in Survivors of Sexual Trauma

iLux Treatment for Meibomian Gland Dysfunction (MGD)

LIFT: Life Improvement Trial

Software Validation Study-Cognitive Status Indicator

Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children

A Study to Evaluate the Safety, Tolerability, and Blood Levels of ACU193 in Participants With MCI or Mild AD

Treatment of Supine Hypertension in Autonomic Failure

Cognitive Effects of Anesthesia on Children

Goal-Directed Sedation in Mechanically Ventilated Infants and Children

Exploring the Effectiveness of Sensor-based Balance Training on Patient Outcome Measures

Chlorthalidone Compared to Hydrochlorothiazide on Endothelial Function

Impact of Yoga on Cognitive Function

Nitric Oxide Administration During Pediatric Cardiopulmonary Bypass Surgery to Prevent Platelet Activation

Health Ahead Comparative Effectiveness Study

Study of Safety and Tolerability of EO2002 in the Treatment of Corneal Edema

Fluoxetine Prevention Trial

The REMIND Study- SPARK Neuro Software Study

Early Diagnosis of Diastolic Dysfunction and Reliability of DSE in Detecting Stress Diastolic Dysfunction

Consumption of Potatoes, Avocados and Chickpeas and Cognitive Function in Older Adults

VCOM Pain Free Research Collaborative